🇺🇸 FDA
Patent

US 7531352

Inducible plasmid vector encoding TGF-β and use thereof

granted A61KA61K48/00A61K48/005

Quick answer

US patent 7531352 (Inducible plasmid vector encoding TGF-β and use thereof) held by The United States of America, as represented by the Department of Health and Human Services expires Mon May 07 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue May 12 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 07 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K48/00, A61K48/005, A61K48/0066, A61P